Financials

News Discussions Technicals Seasonals

PHAL fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

PharmaLundensis AB engages in the provision of biotechnology activities. It offers research and development of medicines and treatment for lung diseases such as chronic obstructive pulmonary disease, chronic bronchitis, and influenza. The company was founded by Staffan Skogvall in 2007 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

PHAL does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company